These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23364181)

  • 21. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing.
    Dar P; Curnow KJ; Gross SJ; Hall MP; Stosic M; Demko Z; Zimmermann B; Hill M; Sigurjonsson S; Ryan A; Banjevic M; Kolacki PL; Koch SW; Strom CM; Rabinowitz M; Benn P
    Am J Obstet Gynecol; 2014 Nov; 211(5):527.e1-527.e17. PubMed ID: 25111587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single molecule sequencing of free DNA from maternal plasma for noninvasive trisomy 21 detection.
    van den Oever JM; Balkassmi S; Verweij EJ; van Iterson M; Adama van Scheltema PN; Oepkes D; van Lith JM; Hoffer MJ; den Dunnen JT; Bakker E; Boon EM
    Clin Chem; 2012 Apr; 58(4):699-706. PubMed ID: 22278607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive prenatal testing.
    Lo JO; Cori D F; Norton ME; Caughey AB
    Obstet Gynecol Surv; 2014 Feb; 69(2):89-99. PubMed ID: 25112487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive prenatal cell-free fetal DNA-based screening for aneuploidies other than trisomy 21.
    Blue Cross Blue Shield Asssociation
    Technol Eval Cent Assess Program Exec Summ; 2014 Dec; 29(7):1-7. PubMed ID: 25577816
    [No Abstract]   [Full Text] [Related]  

  • 26. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18.
    Sparks AB; Struble CA; Wang ET; Song K; Oliphant A
    Am J Obstet Gynecol; 2012 Apr; 206(4):319.e1-9. PubMed ID: 22464072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18.
    Norton ME; Brar H; Weiss J; Karimi A; Laurent LC; Caughey AB; Rodriguez MH; Williams J; Mitchell ME; Adair CD; Lee H; Jacobsson B; Tomlinson MW; Oepkes D; Hollemon D; Sparks AB; Oliphant A; Song K
    Am J Obstet Gynecol; 2012 Aug; 207(2):137.e1-8. PubMed ID: 22742782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X.
    Rava RP; Srinivasan A; Sehnert AJ; Bianchi DW
    Clin Chem; 2014 Jan; 60(1):243-50. PubMed ID: 24046201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management.
    Bayindir B; Dehaspe L; Brison N; Brady P; Ardui S; Kammoun M; Van der Veken L; Lichtenbelt K; Van den Bogaert K; Van Houdt J; Peeters H; Van Esch H; de Ravel T; Legius E; Devriendt K; Vermeesch JR
    Eur J Hum Genet; 2015 Oct; 23(10):1286-93. PubMed ID: 25585704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21.
    Chiu RW; Sun H; Akolekar R; Clouser C; Lee C; McKernan K; Zhou D; Nicolaides KH; Lo YM
    Clin Chem; 2010 Mar; 56(3):459-63. PubMed ID: 20026875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome.
    Tsui DW; Lam YM; Lee WS; Leung TY; Lau TK; Lau ET; Tang MH; Akolekar R; Nicolaides KH; Chiu RW; Lo YM; Chim SS
    PLoS One; 2010 Nov; 5(11):e15069. PubMed ID: 21152411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.
    Nicolaides KH; Syngelaki A; Ashoor G; Birdir C; Touzet G
    Am J Obstet Gynecol; 2012 Nov; 207(5):374.e1-6. PubMed ID: 23107079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.
    Bianchi DW; Platt LD; Goldberg JD; Abuhamad AZ; Sehnert AJ; Rava RP;
    Obstet Gynecol; 2012 May; 119(5):890-901. PubMed ID: 22362253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Overview on Prenatal Screening for Chromosomal Aberrations.
    Hixson L; Goel S; Schuber P; Faltas V; Lee J; Narayakkadan A; Leung H; Osborne J
    J Lab Autom; 2015 Oct; 20(5):562-73. PubMed ID: 25587000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations.
    Tong YK; Ding C; Chiu RW; Gerovassili A; Chim SS; Leung TY; Leung TN; Lau TK; Nicolaides KH; Lo YM
    Clin Chem; 2006 Dec; 52(12):2194-202. PubMed ID: 17040955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies.
    Jiang F; Ren J; Chen F; Zhou Y; Xie J; Dan S; Su Y; Xie J; Yin B; Su W; Zhang H; Wang W; Chai X; Lin L; Guo H; Li Q; Li P; Yuan Y; Pan X; Li Y; Liu L; Chen H; Xuan Z; Chen S; Zhang C; Zhang H; Tian Z; Zhang Z; Jiang H; Zhao L; Zheng W; Li S; Li Y; Wang J; Wang J; Zhang X
    BMC Med Genomics; 2012 Dec; 5():57. PubMed ID: 23198897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
    Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Massively parallel sequencing of maternal plasma DNA in 113 cases of fetal nuchal cystic hygroma.
    Bianchi DW; Prosen T; Platt LD; Goldberg JD; Abuhamad AZ; Rava RP; Sehnert AJ;
    Obstet Gynecol; 2013 May; 121(5):1057-1062. PubMed ID: 23635743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.
    Nicolaides KH; Syngelaki A; Poon LC; Gil MM; Wright D
    Fetal Diagn Ther; 2014; 35(3):185-92. PubMed ID: 24192489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.